Comparative Pathology of Neurodegeneration: Linking Microglial Senescence to Protein Aggregation
Clicks: 2
ID: 283925
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #67 of 70 articles by views in International Journal of Integrated Research and Practice
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis are neurodegenerative disorders that have two pathological characteristics in common: the piling up of misfolded proteins and chronic neuroinflammation. Rising evidence supports the idea that microglia, the central nervous system resident immune cells, have long been known as reactive responders but also must be regarded as active drivers of disease pathology. The following paper examines the comparative pathology of neurodegeneration among discrete disorders with an emphasis on how microglial senescence can be viewed as a unifying process coupling protein aggregation with neurodegeneration. I use analysis of post-mortem human brain tissue and pertinent animal models to determine convergent changes in microglial morphology, gene expression and secretory signature during senescence. These characteristics are dystrophic branching, defective phagocytosis ability, and pro-inflammatory cytokine up-regulation. Notably, senescence of microglia in turn also decreases the clearance of pathological aggregates like amyloid-B, a-synuclein, and TDP-43 and constitutes a feed-forward loop as the accumulation of protein deposits continues to worsen inflammatory signaling and oxidative stresses, which are further disabling microglia. Both common and disease-specific interaction between microglial senescence and aggregateprone proteins is identified by comparative evaluation. In AAD, dystrophic microglia tends to aggregate in proximity to amyloid plaques, when compared to AAD, in Parkinson, the senescence signatures are more linked to nigrostriatal Lewy bodies. Microglial senescence in ALS associates with the broad-based pathology and loss of cortical-spinal tract with TDP-43. This paper combines neuropathological data with molecular and experimental findings to propose a model framework: Microglial senescence may therefore represent an essential pivot point between protein aggregate formation and the neurodegeneration. Intervention in senescence-related pathways, in order to rejuvenate microglial function or up-regulate aggregate clearance, may be a widely applicable therapeutic approach. Together, these results emphasize the potential of the cross-disease comparative method in terms of elucidating the complicated interactions between innate immune age-related changes and proteostatic breakdown in the brain.
| Reference Key |
imported_1760529457_68ef8c3174192
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Anjaria Mihir Bharatkumar |
| Journal | International Journal of Integrated Research and Practice |
| Year | 2025 |
| DOI |
10.25215/31075037.034
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.